# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001571049-17-007711
Filing Date
2017-08-30
Accepted
2017-08-30 16:08:06
Documents
107
Period of Report
2017-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | t1702407-10k.htm | 10-K | 2871994
2 | EXHIBIT 10.38 | t1702407_ex10-38.htm | EX-10.38 | 5330
3 | EXHIBIT 10.39 | t1702407_ex10-39.htm | EX-10.39 | 3366
4 | EXHIBIT 23 | t1702407_ex23.htm | EX-23 | 1827
5 | EXHIBIT 31.1 | t1702407_ex31-1.htm | EX-31.1 | 6805
6 | EXHIBIT 31.2 | t1702407_ex31-2.htm | EX-31.2 | 6788
7 | EXHIBIT 32.1 | t1702407_ex32-1.htm | EX-32.1 | 2861
8 | EXHIBIT 32.2 | t1702407_ex32-2.htm | EX-32.2 | 2917
15 | GRAPHIC | t1702407_chrt-line.jpg | GRAPHIC | 1162362
16 | GRAPHIC | t1702407_ex10-38img01.jpg | GRAPHIC | 325398
17 | GRAPHIC | t1702407_ex10-38img02.jpg | GRAPHIC | 137261
18 | GRAPHIC | t1702407_ex10-39img01.jpg | GRAPHIC | 304352
| Complete submission text file | 0001571049-17-007711.txt |  | 14211824

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE FILE | pahc-20170630.xml | EX-101.INS | 2786961
10 | XBRL SCHEMA FILE | pahc-20170630.xsd | EX-101.SCH | 61890
11 | XBRL CALCULATION FILE | pahc-20170630_cal.xml | EX-101.CAL | 90906
12 | XBRL DEFINITION FILE | pahc-20170630_def.xml | EX-101.DEF | 287254
13 | XBRL LABEL FILE | pahc-20170630_lab.xml | EX-101.LAB | 675678
14 | XBRL PRESENTATION FILE | pahc-20170630_pre.xml | EX-101.PRE | 502061

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-36410 | Film No.: 171060781
SIC: 2834 Pharmaceutical Preparations